TG103
A Study of TG103 Injection in Overweight or Obesity
CSPC Baike (Shandong) Biopharmaceutical Co · Phase 2 · Status n/r · Enrollment 195
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
TG103
CSPC Baike (Shandong) Biopharmaceutical Co · Phase 2 · Status n/r · Enrollment 195
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.